Aeonbiopharma
NYSE: AEON1 known investors
Find your way into Aeonbiopharma
188 people in our graph share verified history with the Aeonbiopharma team — schools, employers, funds. One of them is your warm intro.
Bridget Martell MA, MDunlockedknows John Bencich · together at Achieve Life Sciences (overlapped)
×9knows the team · via University of San Diego
×2knows the team · via Seattle University
AEON Biopharma develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for patients with neuromuscular disorders. The company focuses on expanding access to high-quality neurotoxin therapies through proprietary drug development.
Founders & leadership
RB
Robert BancroftPresident, Chief Executive Officer and Director
JB
John BencichinChief Financial OfficerJohn Bencich is Chief Financial Officer at AEON Biopharma, which develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for neuromuscular disorders. He brings 25 years of experience in life sciences and biotechnology, with expertise in corporate strategy, capital raising, mergers and acquisitions, and financial leadership across early-stage companies and NASDAQ-listed firms.
CO
Chad OhinChief Medical Officer
AW
Alex WilsoninChief Legal & Strategy Officer; Corporate SecretaryAlex Wilson is Chief Legal & Strategy Officer and Corporate Secretary at AEON Biopharma. He previously practiced mergers and acquisitions, corporate governance, and capital markets law at O'Melveny & Myers LLP, and served as Chief Legal Officer at Glaukos Corporation, handling securities law, intellectual property, regulatory matters, and corporate transactions.
JS
Jennifer SyinChief Accounting OfficerJennifer Sy holds a B.A. in Business Economics with a minor in Accounting from UCLA and has spent over 18 years in finance and accounting roles across healthcare, technology, and consumer services, including positions as Corporate Controller at Nogin (where she led a SPAC IPO and ERP implementation), Director of Finance at Prospect Medical Holdings overseeing 16+ hospitals and clinics, and external auditor at Deloitte.
Investors · 1
Competitors · 3
by search overlap
Simply Wall St7 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TradingView7 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwits6 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies competing with Aeonbiopharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Aeonbiopharma do?
- AEON Biopharma develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for patients with neuromuscular disorders. The company focuses on expanding access to high-quality neurotoxin therapies through proprietary drug development.
- Who are Aeonbiopharma's investors?
- Aeonbiopharma's investors include Longitude Capital.